JPWO2021158534A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021158534A5 JPWO2021158534A5 JP2022547671A JP2022547671A JPWO2021158534A5 JP WO2021158534 A5 JPWO2021158534 A5 JP WO2021158534A5 JP 2022547671 A JP2022547671 A JP 2022547671A JP 2022547671 A JP2022547671 A JP 2022547671A JP WO2021158534 A5 JPWO2021158534 A5 JP WO2021158534A5
- Authority
- JP
- Japan
- Prior art keywords
- car
- cells
- hapten
- cell
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062969917P | 2020-02-04 | 2020-02-04 | |
| US62/969,917 | 2020-02-04 | ||
| PCT/US2021/016194 WO2021158534A1 (en) | 2020-02-04 | 2021-02-02 | Methods and compositions for stimulation of chimeric antigen receptor t cells with hapten labelled cells |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023513156A JP2023513156A (ja) | 2023-03-30 |
| JPWO2021158534A5 true JPWO2021158534A5 (https=) | 2024-02-09 |
| JP2023513156A5 JP2023513156A5 (https=) | 2024-02-09 |
| JP7744914B2 JP7744914B2 (ja) | 2025-09-26 |
Family
ID=77200468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022547671A Active JP7744914B2 (ja) | 2020-02-04 | 2021-02-02 | ハプテン標識細胞によりキメラ抗原受容体ｔ細胞を刺激する方法およびそのための組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230172981A1 (https=) |
| EP (1) | EP4100026A4 (https=) |
| JP (1) | JP7744914B2 (https=) |
| KR (1) | KR20220164474A (https=) |
| CN (1) | CN115397440A (https=) |
| AU (1) | AU2021216554A1 (https=) |
| CA (1) | CA3169804A1 (https=) |
| IL (1) | IL295074A (https=) |
| WO (1) | WO2021158534A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2934532B1 (en) | 2012-12-20 | 2019-10-23 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| JP7282521B2 (ja) | 2016-04-08 | 2023-05-29 | パーデュー・リサーチ・ファウンデイション | Ｃａｒ ｔ細胞療法のための方法および組成物 |
| JP7178355B2 (ja) | 2017-02-28 | 2022-11-25 | エンドサイト・インコーポレイテッド | Ｃａｒ ｔ細胞療法のための組成物および方法 |
| JP7549303B2 (ja) | 2018-01-22 | 2024-09-11 | エンドサイト・インコーポレイテッド | Ｃａｒ ｔ細胞の使用方法 |
| SG11202007426XA (en) * | 2018-02-06 | 2020-09-29 | Seattle Childrens Hospital Dba Seattle Childrens Res Inst | Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors |
| CN112105382A (zh) | 2018-02-23 | 2020-12-18 | 恩多塞特公司 | 用于car t细胞疗法的顺序方法 |
| AU2021217003A1 (en) | 2020-02-04 | 2022-09-15 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Anti-dinitrophenol chimeric antigen receptors |
| WO2023178073A2 (en) * | 2022-03-15 | 2023-09-21 | Celledit Llc | Use of antigen presenting cells to enhance car-t cell therapy |
| WO2024206913A2 (en) * | 2023-03-31 | 2024-10-03 | Northwestern University | Compositions for antigen-specific immune cell activation |
| WO2024251866A1 (en) * | 2023-06-06 | 2024-12-12 | Danmarks Tekniske Universitet | A synthetic cellular advanced signal adapter (scasa) system |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020004052A1 (en) * | 1990-05-08 | 2002-01-10 | David Berd | Composition comprising a tumor cell extract and method of using the composition |
| KR102376244B1 (ko) * | 2014-12-24 | 2022-03-21 | 오토러스 리미티드 | 세포 |
| WO2017075440A1 (en) * | 2015-10-30 | 2017-05-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Targeted cancer therapy |
| CN115404196A (zh) | 2016-07-13 | 2022-11-29 | 哈佛学院院长等 | 抗原呈递细胞模拟支架及其制备和使用方法 |
| US10617720B2 (en) * | 2016-10-20 | 2020-04-14 | Miltenyi Biotech, GmbH | Chimeric antigen receptor specific for tumor cells |
| EP3336107A1 (en) * | 2016-12-15 | 2018-06-20 | Miltenyi Biotec GmbH | Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor |
| US11590214B2 (en) * | 2016-12-21 | 2023-02-28 | Danmarks Tekniskte Universitet | Antigen presenting scaffolds for immune-cell manipulation |
| CN110612119B (zh) * | 2017-02-07 | 2024-10-29 | 西雅图儿童医院（Dba西雅图儿童研究所） | 磷脂醚(ple)car t细胞肿瘤靶向(ctct)剂 |
| WO2019060425A1 (en) | 2017-09-19 | 2019-03-28 | Massachusetts Institute Of Technology | COMPOSITIONS FOR CHIMERIC ANTIGENIC RECEPTOR T CELL THERAPY AND USES THEREOF |
| MX2020004185A (es) * | 2017-09-27 | 2021-01-08 | Univ Southern California | Nuevas plataformas para coestimulacion, nuevos diseños car y otras mejoras para terapia celular adoptiva. |
| SG11202007426XA (en) | 2018-02-06 | 2020-09-29 | Seattle Childrens Hospital Dba Seattle Childrens Res Inst | Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors |
| KR20210074274A (ko) * | 2018-08-06 | 2021-06-21 | 시애틀 칠드런즈 호스피탈 디/비/에이 시애틀 칠드런즈 리서치 인스티튜트 | 합텐 표지된 세포로의 키메라 항원 수용체 t 세포의 자극을 위한 방법 및 조성물 |
-
2021
- 2021-02-02 IL IL295074A patent/IL295074A/en unknown
- 2021-02-02 KR KR1020227030136A patent/KR20220164474A/ko active Pending
- 2021-02-02 CN CN202180019063.XA patent/CN115397440A/zh active Pending
- 2021-02-02 WO PCT/US2021/016194 patent/WO2021158534A1/en not_active Ceased
- 2021-02-02 JP JP2022547671A patent/JP7744914B2/ja active Active
- 2021-02-02 EP EP21751276.3A patent/EP4100026A4/en active Pending
- 2021-02-02 CA CA3169804A patent/CA3169804A1/en active Pending
- 2021-02-02 US US17/758,960 patent/US20230172981A1/en active Pending
- 2021-02-02 AU AU2021216554A patent/AU2021216554A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112218653B (zh) | 用于靶向不同的多种抗原的表达反向通用嵌合抗原受体的免疫细胞及其制备方法和用于治疗癌症、感染和自身免疫性病症的用途 | |
| US12258405B2 (en) | CD3 antibody and pharmaceutical use thereof | |
| CN113082201B (zh) | 刺激t细胞介导的对表达抗原的细胞群的免疫应答的方法 | |
| Yeku et al. | Adoptive T-cell therapy for solid tumors | |
| JP2021532818A5 (https=) | ||
| CN112969476B (zh) | 多特异性蛋白分子 | |
| US8440188B2 (en) | Therapeutic and diagnostic anti-HSP70 antibodies | |
| TW202227124A (zh) | 用於體內產生ｃａｒ表現細胞的組成物和方法 | |
| JPWO2021158534A5 (https=) | ||
| KR20160127130A (ko) | T 세포 수용체 베타 불변 영역에 대한 항원 결합 도메인을 갖는 키메라 항원 수용체(car) | |
| EP3294319A1 (en) | T cell recruiting polypeptides based on cd3 reactivity | |
| TW201900672A (zh) | 改良之抗原結合受體型式 | |
| HUT53153A (en) | Process for producing bispecific monoclonal antibody | |
| JP2021513961A5 (https=) | ||
| JPWO2020033272A5 (https=) | ||
| CN110036028A (zh) | 抗il1-rap抗体 | |
| Pan et al. | Characterization of a novel bispecific antibody targeting tissue factor-positive tumors with T cell engagement | |
| JPWO2020176497A5 (https=) | ||
| CN118786142A (zh) | 用于治疗肿瘤的ror1 car或ror1/cd19双car t细胞 | |
| JPWO2019160904A5 (https=) | ||
| CN114853897A (zh) | 抗cd19/cd22/cd3三特异性抗体及用途 | |
| WO2019120063A1 (zh) | 低pH插入肽及其组合物 | |
| Canevari et al. | Approaches to implement bispecific antibody treatment of ovarian carcinoma | |
| CN113660954A (zh) | 癌症治疗用药物 | |
| US20260000782A1 (en) | Itgb2-mediated drug delivery system |